logo
Plus   Neg
Share
Email

China Pharma Posts Wider Loss In FY19 - Quick Facts

China Pharma Holdings, Inc. (CPHI) reported a full year 2019 loss per common share of $0.48 compared to a loss of $0.25, previous year. Gross margin was 13.6% compared to 16.0%. Gross profit was $1.5 million, compared to $2.0 million, previous year.

Full year 2019 revenue decreased 11.4% to $11.0 million from $12.3 million, prior year. The company said this decrease in sales revenue was mainly due to the increased standards of drug tender procurement of GPO and the decreased "drug ratio".

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) reported a profit for the fourth-quarter that increased 23.3 percent from last year, led by display and memory chip businesses.Quarterly revenue grew 2.8 percent from the prior year. The company expects overall profit to weaken in the first quarter of 2021. Facebook Inc. (FB) Wednesday reported a fourth-quarter profit that increased from a year ago, driven largely by 33% growth in revenues. The social media giant's earnings and revenues for the quarter trumped Wall Street estimates, but the company warned of "significant uncertainty" in 2021. Menlo Park,... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker's revenues topped $100 billion driven by strong demand for latest iPhones and wearables segment. Apple's first-quarter profit rose to $28.76 billion or $1.68 per share from $22.24 billion...
RELATED NEWS
Follow RTT